4/15
09:37 pm
tem
Tempus AI (TEM) Unveils Cancer Test Kit, Soars 13.9% [Yahoo! Finance]
Medium
Report
Tempus AI (TEM) Unveils Cancer Test Kit, Soars 13.9% [Yahoo! Finance]
4/15
08:30 am
tem
Tempus and Predicta Biosciences Announce Collaboration to Expand Life Sciences Access to Ultrasensitive Whole-Genome Sequencing Assay for Hematologic Malignancies and MRD Monitoring
High
Report
Tempus and Predicta Biosciences Announce Collaboration to Expand Life Sciences Access to Ultrasensitive Whole-Genome Sequencing Assay for Hematologic Malignancies and MRD Monitoring
4/14
08:30 am
tem
Tempus Announces 31 Abstracts for Presentation at the American Association for Cancer Research Annual Meeting 2026
Medium
Report
Tempus Announces 31 Abstracts for Presentation at the American Association for Cancer Research Annual Meeting 2026
4/13
08:51 am
tem
Tempus AI (TEM) was upgraded by TD Cowen from "hold" to "buy". They now have a $65.00 price target on the stock.
Medium
Report
Tempus AI (TEM) was upgraded by TD Cowen from "hold" to "buy". They now have a $65.00 price target on the stock.
4/13
08:34 am
tem
Tempus AI (TEM) is now covered by Jefferies Financial Group Inc.. They set an "underperform" rating and a $35.00 price target on the stock.
Medium
Report
Tempus AI (TEM) is now covered by Jefferies Financial Group Inc.. They set an "underperform" rating and a $35.00 price target on the stock.
4/13
08:30 am
tem
Tempus Launches Automated “Active Follow-Up” Service to Support Guideline-Concordant Care
Medium
Report
Tempus Launches Automated “Active Follow-Up” Service to Support Guideline-Concordant Care
4/9
08:30 am
tem
Tempus Announces Strategic Collaboration with Gilead to Advance Oncology R&D Through RWE
Medium
Report
Tempus Announces Strategic Collaboration with Gilead to Advance Oncology R&D Through RWE
4/8
04:01 pm
tem
Tempus to Present at the 25th Annual Needham Virtual Healthcare Conference
Medium
Report
Tempus to Present at the 25th Annual Needham Virtual Healthcare Conference
4/1
08:48 am
tem
Tempus and Medtronic Announce ALERT Trial Results Showing AI-Driven EHR Notifications Improve Treatment for Significant Valvular Heart Disease [Yahoo! Finance]
Low
Report
Tempus and Medtronic Announce ALERT Trial Results Showing AI-Driven EHR Notifications Improve Treatment for Significant Valvular Heart Disease [Yahoo! Finance]
4/1
08:30 am
tem
Tempus and Medtronic Announce ALERT Trial Results Showing AI-Driven EHR Notifications Improve Treatment for Significant Valvular Heart Disease
Low
Report
Tempus and Medtronic Announce ALERT Trial Results Showing AI-Driven EHR Notifications Improve Treatment for Significant Valvular Heart Disease
3/31
12:58 pm
tem
Jim Cramer on Tempus AI: “It's a Decent Spec, I Would Hold on to Some, But Not All” [Yahoo! Finance]
Low
Report
Jim Cramer on Tempus AI: “It's a Decent Spec, I Would Hold on to Some, But Not All” [Yahoo! Finance]
3/30
11:29 am
tem
Tempus AI (TEM) had its price target lowered by Guggenheim from $95.00 to $60.00. They now have a "buy" rating on the stock.
Low
Report
Tempus AI (TEM) had its price target lowered by Guggenheim from $95.00 to $60.00. They now have a "buy" rating on the stock.
3/20
04:46 pm
tem
H.C. Wainwright Raises Tempus AI (TEM) Price Target to $95 [Yahoo! Finance]
Medium
Report
H.C. Wainwright Raises Tempus AI (TEM) Price Target to $95 [Yahoo! Finance]
3/17
08:30 am
tem
Tempus and Blood Cancer United® Announce Collaboration to Develop One Of the Largest Pediatric Acute Myeloid Leukemia Real-World Data Registries
Low
Report
Tempus and Blood Cancer United® Announce Collaboration to Develop One Of the Largest Pediatric Acute Myeloid Leukemia Real-World Data Registries
3/15
01:45 pm
tem
Cathie Wood buys $2 million of tumbling AI stock [Yahoo! Finance]
Low
Report
Cathie Wood buys $2 million of tumbling AI stock [Yahoo! Finance]
3/11
08:30 am
tem
Tempus Announces Study Highlighting the Role of Advanced Genomic Profiling Features in Identifying Clinically Actionable Findings
Medium
Report
Tempus Announces Study Highlighting the Role of Advanced Genomic Profiling Features in Identifying Clinically Actionable Findings
3/11
08:03 am
tem
Tempus AI (TEM) had its "buy" rating reaffirmed by Needham & Company LLC. They now have a $75.00 price target on the stock.
Medium
Report
Tempus AI (TEM) had its "buy" rating reaffirmed by Needham & Company LLC. They now have a $75.00 price target on the stock.
3/9
01:51 pm
tem
Tempus AI (TEM) had its price target raised by HC Wainwright from $89.00 to $95.00. They now have a "buy" rating on the stock.
Medium
Report
Tempus AI (TEM) had its price target raised by HC Wainwright from $89.00 to $95.00. They now have a "buy" rating on the stock.
3/7
07:22 am
tem
Tempus AI, Inc. (TEM) Announces Strategic Deal with Merck to Fast-Track AI-Driven Precision Medicine [Yahoo! Finance]
Low
Report
Tempus AI, Inc. (TEM) Announces Strategic Deal with Merck to Fast-Track AI-Driven Precision Medicine [Yahoo! Finance]
3/5
08:39 pm
tem
AI-Powered Tempus Inks New Multi-Year Merck Deal [Yahoo! Finance]
Low
Report
AI-Powered Tempus Inks New Multi-Year Merck Deal [Yahoo! Finance]
3/3
12:40 pm
tem
Tempus AI (TEM) had its price target lowered by Morgan Stanley from $85.00 to $70.00. They now have an "overweight" rating on the stock.
Low
Report
Tempus AI (TEM) had its price target lowered by Morgan Stanley from $85.00 to $70.00. They now have an "overweight" rating on the stock.
3/3
08:30 am
tem
Tempus Announces Strategic Collaboration Agreement with Merck to Accelerate AI-Driven Precision Medicine
Medium
Report
Tempus Announces Strategic Collaboration Agreement with Merck to Accelerate AI-Driven Precision Medicine
2/28
01:30 am
tem
Low
Report
2/26
08:30 am
tem
Tempus to Participate in the Morgan Stanley Technology, Media & Telecom Conference
Medium
Report
Tempus to Participate in the Morgan Stanley Technology, Media & Telecom Conference
2/25
04:43 pm
tem
Tempus AI: No AI Interruption Detected [Seeking Alpha]
Medium
Report
Tempus AI: No AI Interruption Detected [Seeking Alpha]